1. Home
  2. OLMA vs UVE Comparison

OLMA vs UVE Comparison

Compare OLMA & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • UVE
  • Stock Information
  • Founded
  • OLMA 2006
  • UVE 1990
  • Country
  • OLMA United States
  • UVE United States
  • Employees
  • OLMA N/A
  • UVE N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • UVE Property-Casualty Insurers
  • Sector
  • OLMA Health Care
  • UVE Finance
  • Exchange
  • OLMA Nasdaq
  • UVE Nasdaq
  • Market Cap
  • OLMA 725.5M
  • UVE 666.1M
  • IPO Year
  • OLMA 2020
  • UVE 1992
  • Fundamental
  • Price
  • OLMA $8.44
  • UVE $28.27
  • Analyst Decision
  • OLMA Strong Buy
  • UVE
  • Analyst Count
  • OLMA 6
  • UVE 0
  • Target Price
  • OLMA $23.00
  • UVE N/A
  • AVG Volume (30 Days)
  • OLMA 1.5M
  • UVE 186.8K
  • Earning Date
  • OLMA 11-11-2025
  • UVE 10-23-2025
  • Dividend Yield
  • OLMA N/A
  • UVE 2.72%
  • EPS Growth
  • OLMA N/A
  • UVE N/A
  • EPS
  • OLMA N/A
  • UVE 2.28
  • Revenue
  • OLMA N/A
  • UVE $1,567,371,000.00
  • Revenue This Year
  • OLMA N/A
  • UVE $1.87
  • Revenue Next Year
  • OLMA N/A
  • UVE N/A
  • P/E Ratio
  • OLMA N/A
  • UVE $12.40
  • Revenue Growth
  • OLMA N/A
  • UVE 5.64
  • 52 Week Low
  • OLMA $2.86
  • UVE $18.72
  • 52 Week High
  • OLMA $13.51
  • UVE $30.48
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 42.90
  • UVE 55.52
  • Support Level
  • OLMA $6.65
  • UVE $27.89
  • Resistance Level
  • OLMA $11.06
  • UVE $30.02
  • Average True Range (ATR)
  • OLMA 0.82
  • UVE 0.89
  • MACD
  • OLMA -0.42
  • UVE -0.17
  • Stochastic Oscillator
  • OLMA 36.58
  • UVE 54.80

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

Share on Social Networks: